A citation-based method for searching scientific literature

Leia C Shuhaibar, Nabil Kaci, Jeremy R Egbert, Thibault Horville, Léa Loisay, Giulia Vigone, Tracy F Uliasz, Emilie Dambroise, Mark R Swingle, Richard E Honkanen, Martin Biosse Duplan, Laurinda A Jaffe, Laurence Legeai-Mallet. JCI Insight 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice.
Takei Kake, Hidetomo Kitamura, Yuichiro Adachi, Tetsuro Yoshioka, Tomoyuki Watanabe, Hiroaki Matsushita, Toshihito Fujii, Eri Kondo, Takanori Tachibe, Yosuke Kawase,[...]. Am J Physiol Endocrinol Metab 2009
59
100

Dephosphorylation of juxtamembrane serines and threonines of the NPR2 guanylyl cyclase is required for rapid resumption of oocyte meiosis in response to luteinizing hormone.
Leia C Shuhaibar, Jeremy R Egbert, Aaron B Edmund, Tracy F Uliasz, Deborah M Dickey, Siu-Pok Yee, Lincoln R Potter, Laurinda A Jaffe. Dev Biol 2016
31
100

Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.
Florence Lorget, Nabil Kaci, Jeff Peng, Catherine Benoist-Lasselin, Emilie Mugniery, Todd Oppeneer, Dan J Wendt, Sean M Bell, Sherry Bullens, Stuart Bunting,[...]. Am J Hum Genet 2012
104
100

C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia.
Robert C Olney, Timothy C R Prickett, Eric A Espiner, William G Mackenzie, Angela L Duker, Colleen Ditro, Bernhard Zabel, Tomonobu Hasegawa, Hiroshi Kitoh, Arthur S Aylsworth,[...]. J Clin Endocrinol Metab 2015
21
100

Type II cGMP-dependent protein kinase negatively regulates fibroblast growth factor signaling by phosphorylating Raf-1 at serine 43 in rat chondrosarcoma cells.
Norio Kamemura, Sara Murakami, Hiroaki Komatsu, Masahiro Sawanoi, Kenji Miyamoto, Kazumi Ishidoh, Koji Kishimoto, Akihiko Tsuji, Keizo Yuasa. Biochem Biophys Res Commun 2017
8
100

Osteocrin is a specific ligand of the natriuretic Peptide clearance receptor that modulates bone growth.
Pierre Moffatt, Gethin Thomas, Karine Sellin, Marie-Claude Bessette, François Lafrenière, Omar Akhouayri, René St-Arnaud, Christian Lanctôt. J Biol Chem 2007
50
100

A novel loss-of-function mutation in Npr2 clarifies primary role in female reproduction and reveals a potential therapy for acromesomelic dysplasia, Maroteaux type.
Krista A Geister, Michelle L Brinkmeier, Minnie Hsieh, Susan M Faust, I Jill Karolyi, Joseph E Perosky, Kenneth M Kozloff, Marco Conti, Sally A Camper. Hum Mol Genet 2013
41
100

Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.
Akihiro Yasoda, Yasato Komatsu, Hideki Chusho, Takashi Miyazawa, Ami Ozasa, Masako Miura, Tatsuya Kurihara, Tomohiro Rogi, Shoji Tanaka, Michio Suda,[...]. Nat Med 2004
265
100

Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial.
Ravi Savarirayan, Louise Tofts, Melita Irving, William Wilcox, Carlos A Bacino, Julie Hoover-Fong, Rosendo Ullot Font, Paul Harmatz, Frank Rutsch, Michael B Bober,[...]. Lancet 2020
26
100

C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia.
Ravi Savarirayan, Melita Irving, Carlos A Bacino, Bret Bostwick, Joel Charrow, Valerie Cormier-Daire, Kim-Hanh Le Quan Sang, Patricia Dickson, Paul Harmatz, John Phillips,[...]. N Engl J Med 2019
58
100

Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia.
Stéphanie Pannier, Emilie Mugniery, Aurélie Jonquoy, Catherine Benoist-Lasselin, Thierry Odent, Jean-Philippe Jais, Arnold Munnich, Laurence Legeai-Mallet. Bone 2010
20
100

Overgrowth syndrome associated with a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene.
Kohji Miura, Ok-Hwa Kim, Hey Ran Lee, Noriyuki Namba, Toshimi Michigami, Won Joon Yoo, In Ho Choi, Keiichi Ozono, Tae-Joon Cho. Am J Med Genet A 2014
47
100

Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.
Daniel J Wendt, Melita Dvorak-Ewell, Sherry Bullens, Florence Lorget, Sean M Bell, Jeff Peng, Sianna Castillo, Mika Aoyagi-Scharber, Charles A O'Neill, Pavel Krejci,[...]. J Pharmacol Exp Ther 2015
57
100

Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.
Ami Ozasa, Yasato Komatsu, Akihiro Yasoda, Masako Miura, Yoko Sakuma, Yuko Nakatsuru, Hiroshi Arai, Nobuyuki Itoh, Kazuwa Nakao. Bone 2005
46
100

The observed human sperm mutation frequency cannot explain the achondroplasia paternal age effect.
Irene Tiemann-Boege, William Navidi, Raji Grewal, Dan Cohn, Brenda Eskenazi, Andrew J Wyrobek, Norman Arnheim. Proc Natl Acad Sci U S A 2002
101
100

Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature.
Robert C Olney, Hülya Bükülmez, Cynthia F Bartels, Timothy C R Prickett, Eric A Espiner, Lincoln R Potter, Matthew L Warman. J Clin Endocrinol Metab 2006
117
100

A functional screen provides evidence for a conserved, regulatory, juxtamembrane phosphorylation site in guanylyl cyclase a and B.
Andrea R Yoder, Jerid W Robinson, Deborah M Dickey, Joshua Andersland, Beth A Rose, Matthew D Stone, Timothy J Griffin, Lincoln R Potter. PLoS One 2012
22
100

Luteinizing hormone reduces the activity of the NPR2 guanylyl cyclase in mouse ovarian follicles, contributing to the cyclic GMP decrease that promotes resumption of meiosis in oocytes.
Jerid W Robinson, Meijia Zhang, Leia C Shuhaibar, Rachael P Norris, Andreas Geerts, Frank Wunder, John J Eppig, Lincoln R Potter, Laurinda A Jaffe. Dev Biol 2012
88
100

Acromesomelic dysplasia, type maroteaux caused by novel loss-of-function mutations of the NPR2 gene: Three case reports.
Wei Wang, Mi Hyun Song, Kohji Miura, Makoto Fujiwara, Nobutoshi Nawa, Yasuhisa Ohata, Taichi Kitaoka, Takuo Kubota, Noriyuki Namba, Dong Kyu Jin,[...]. Am J Med Genet A 2016
20
100

Live imaging analysis of the growth plate in a murine long bone explanted culture system.
Keisho Hirota, Akihiro Yasoda, Yugo Kanai, Yohei Ueda, Ichiro Yamauchi, Takafumi Yamashita, Yoriko Sakane, Toshihito Fujii, Nobuya Inagaki. Sci Rep 2018
6
100

Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.
Cynthia F Bartels, Hulya Bükülmez, Pius Padayatti, David K Rhee, Conny van Ravenswaaij-Arts, Richard M Pauli, Stefan Mundlos, David Chitayat, Ling-Yu Shih, Lihadh I Al-Gazali,[...]. Am J Hum Genet 2004
228
100

Dwarfism and early death in mice lacking C-type natriuretic peptide.
H Chusho, N Tamura, Y Ogawa, A Yasoda, M Suda, T Miyazawa, K Nakamura, K Nakao, T Kurihara, Y Komatsu,[...]. Proc Natl Acad Sci U S A 2001
330
100

Regulation of the Natriuretic Peptide Receptor 2 (Npr2) by Phosphorylation of Juxtamembrane Serine and Threonine Residues Is Essential for Bifurcation of Sensory Axons.
Hannes Schmidt, Deborah M Dickey, Alexandre Dumoulin, Marie Octave, Jerid W Robinson, Ralf Kühn, Robert Feil, Lincoln R Potter, Fritz G Rathjen. J Neurosci 2018
8
100

Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.
Akihiro Yasoda, Hidetomo Kitamura, Toshihito Fujii, Eri Kondo, Naoaki Murao, Masako Miura, Naotetsu Kanamoto, Yasato Komatsu, Hiroshi Arai, Kazuwa Nakao. Endocrinology 2009
79
100



Guanylyl cyclase structure, function and regulation.
Lincoln R Potter. Cell Signal 2011
151
100

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions.
Lincoln R Potter, Sarah Abbey-Hosch, Deborah M Dickey. Endocr Rev 2006
670
100

Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.
F Rousseau, J Bonaventure, L Legeai-Mallet, A Pelet, J M Rozet, P Maroteaux, M Le Merrer, A Munnich. Nature 1994
650
100


Bi-allelic Loss-of-Function Mutations in the NPR-C Receptor Result in Enhanced Growth and Connective Tissue Abnormalities.
Eveline Boudin, Tjeerd R de Jong, Tim C R Prickett, Bruno Lapauw, Kaatje Toye, Viviane Van Hoof, Ilse Luyckx, Aline Verstraeten, Hugo S A Heymans, Eelco Dulfer,[...]. Am J Hum Genet 2018
11
100

Exogenous C-type natriuretic peptide restores normal growth and prevents early growth plate closure in its deficient rats.
Keisho Hirota, Mayumi Furuya, Naomi Morozumi, Kazunori Yoshikiyo, Takafumi Yotsumoto, Toshimasa Jindo, Ryuichi Nakamura, Koichiro Murakami, Yohei Ueda, Takeshi Hanada,[...]. PLoS One 2018
6
100

The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.
N Matsukawa, W J Grzesik, N Takahashi, K N Pandey, S Pang, M Yamauchi, O Smithies. Proc Natl Acad Sci U S A 1999
312
100

An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene.
Kohji Miura, Noriyuki Namba, Makoto Fujiwara, Yasuhisa Ohata, Hidekazu Ishida, Taichi Kitaoka, Takuo Kubota, Haruhiko Hirai, Chikahisa Higuchi, Noriyuki Tsumaki,[...]. PLoS One 2012
73
100

Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development.
Rumi Hachiya, Yuko Ohashi, Yasutomi Kamei, Takayoshi Suganami, Hiroshi Mochizuki, Norimasa Mitsui, Masaaki Saitoh, Masako Sakuragi, Gen Nishimura, Hirofumi Ohashi,[...]. J Clin Endocrinol Metab 2007
48
100



Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype.
Shunichi Murakami, Gener Balmes, Sandra McKinney, Zhaoping Zhang, David Givol, Benoit de Crombrugghe. Genes Dev 2004
200
100


ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism.
Naomi Morozumi, Takafumi Yotsumoto, Akira Yamaki, Kazunori Yoshikiyo, Sayaka Yoshida, Ryuichi Nakamura, Toshimasa Jindo, Mayumi Furuya, Hiroaki Maeda, Yoshiharu Minamitake,[...]. PLoS One 2019
4
100

Achondroplasia: Development, pathogenesis, and therapy.
David M Ornitz, Laurence Legeai-Mallet. Dev Dyn 2017
83
100



C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and -independent pathways.
Hanga Agoston, Sameena Khan, Claudine G James, J Ryan Gillespie, Rosa Serra, Lee-Anne Stanton, Frank Beier. BMC Dev Biol 2007
66
100

A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3.
Y Wang, M K Spatz, K Kannan, H Hayk, A Avivi, M Gorivodsky, M Pines, A Yayon, P Lonai, D Givol. Proc Natl Acad Sci U S A 1999
167
100

Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism.
W C Su, M Kitagawa, N Xue, B Xie, S Garofalo, J Cho, C Deng, W A Horton, X Y Fu. Nature 1997
253
100


Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3).
J Jaubert, F Jaubert, N Martin, L L Washburn, B K Lee, E M Eicher, J L Guénet. Proc Natl Acad Sci U S A 1999
99
100

Knock-in human FGFR3 achondroplasia mutation as a mouse model for human skeletal dysplasia.
Yi-Ching Lee, I-Wen Song, Ya-Ju Pai, Sheng-De Chen, Yuan-Tsong Chen. Sci Rep 2017
22
100

Dephosphorylation of the NPR2 guanylyl cyclase contributes to inhibition of bone growth by fibroblast growth factor.
Leia C Shuhaibar, Jerid W Robinson, Giulia Vigone, Ninna P Shuhaibar, Jeremy R Egbert, Valentina Baena, Tracy F Uliasz, Deborah Kaback, Siu-Pok Yee, Robert Feil,[...]. Elife 2017
16
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.